The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of SNS-301 plus pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN).
 
Alain Patrick Algazi
Stock and Other Ownership Interests - Onchilles Pharma; OncoSec; Sensei Biotherapeutics; Valitor
Consulting or Advisory Role - Array BioPharma; Onchilles Pharma; OncoSec; Regeneron; Sensei Biotherapeutics; Tentarix Biotherapeutics; Valitor; Venn Biosciences Corporation; Worldwide Clinical Trials
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Ascendis Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Genentech (Inst); Idera (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Oncosec (Inst); OncoSec (Inst); Sensei Biotherapeutics (Inst); Tessa Therapeutics (Inst); Vaccinex (Inst)
Travel, Accommodations, Expenses - OncoSec
(OPTIONAL) Uncompensated Relationships - Merck; Sensei Biotherapeutics
 
William Smith
Research Funding - Alliance for Multispecialty Research, LLC
 
Justine Yang Bruce
Stock and Other Ownership Interests - ImageMoverMD (I)
Consulting or Advisory Role - IDEAYA Biosciences; Istari Oncology; Kura Oncology; Lilly; Merck; OncLive/MJH Life Sciences
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kura Oncology (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Sensei Biotherapeutics (Inst)
 
Dong Moon Shin
Research Funding - Bristol-Myers Squibb; Loxo; Sensei Biotherapeutics
Patents, Royalties, Other Intellectual Property - UpToDate
 
Ann Wild Gramza
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Caris Life Sciences
 
Michael J. Jelinek
No Relationships to Disclose
 
Jaswinder Singh
No Relationships to Disclose
 
Krzysztof Misiukiewicz
Consulting or Advisory Role - Bayer; Merck
Speakers' Bureau - Bayer; Merck
 
Dhaval Shah
No Relationships to Disclose
 
Jean S. Campbell
Employment - Sensei Biotherapeutics
Stock and Other Ownership Interests - Sensei Biotherapeutics
Patents, Royalties, Other Intellectual Property - Alvaxa Biosciences
 
Robert Hamilton Pierce
Employment - Dr's Hope; Sensei Biotherapeutics
Leadership - Alvaxa Biosciences (I)
Stock and Other Ownership Interests - Alvaxa Biosciences; Five Prime Therapeutics (I); OncoSec; Sensei Biotherapeutics
Consulting or Advisory Role - Ideaya Biosciences (I)